The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer treatment—antibody-drug conjugates, bispecifics and radiopharmaceuticals—while anti-TIGIT therapies made a bit of a comeback. https://hubs.li/Q02QBXrM0 #ESMO
BioSpace
Internet News
West Des Moines, Iowa 117,366 followers
The leading source for biopharma news and jobs. Connecting industry pioneers with talented professionals.
About us
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.
- Website
-
http://www.biospace.com/
External link for BioSpace
- Industry
- Internet News
- Company size
- 11-50 employees
- Headquarters
- West Des Moines, Iowa
- Type
- Privately Held
- Founded
- 1985
- Specialties
- biotech jobs, pharma jobs, biotech news, pharma news, and life sciences news
Locations
-
Primary
3001 Westown Pkwy
#101
West Des Moines, Iowa 50266, US
Employees at BioSpace
-
Greg Slabodkin
-
Dr. D. Martin Alexander Gershon, MD, JD, MPH
AI & Digital Health Innovation Keynote•Linkedin “Top Voice” Venture Capital, Entrepreneurship, & Fundraising•Techstars Sr EIR•Goldman…
-
Angela Gabriel
Content Manager (Life Sciences Careers) at BioSpace
-
Lori Ellis (Katz)
Market Landscape Observer | Advisor | Moderator | Occasional Speaker - Focusing on Market & Customer Understanding
Updates
-
Johnson & Johnson racked up its third non-small cell lung cancer approval for Rybrevant this year. https://hubs.li/Q02QBZ1X0
FDA Tracker: J&J Scores Third NSCLC Approval for Rybrevant This Year
biospace.com
-
Novo Nodrisk’s cannabinoid receptor–targeting obesity pill was picked up in the $1.1 billion acquisition of Inversago Pharmaceuticals last year. https://hubs.li/Q02QBswx0
Novo’s Next-Gen CB1 Drug Leads to Weight Loss in Phase II, but Neuropsychiatric Events Reported
biospace.com
-
An unusual placebo effect in Aligos Therapeutics Phase IIa trial is driving shareholder skepticism for its metabolic dysfunction-associated steatohepatitis candidate, according to Jefferies analyst Michael Yee. https://hubs.li/Q02QBbSY0 #MASH #Aligos
Aligos Claims Mid-Stage Win in MASH, But Investors Are Skeptical
biospace.com
-
With Thursday’s positive opinion from the Committee for Medicinal Products for Human Use, the matter now heads to the European Commission which will have the final say on whether Wegovy’s label will be updated. https://hubs.li/Q02QBwM60 Novo Nordisk #Wegovy
Novo Secures EU Panel’s Backing for Cardiovascular Use of Wegovy
biospace.com
-
While unlikely to pass this year, given the Democrats’ control over the White House and Senate, the proposed legislation might be a harbinger of the Republicans’ agenda next year for the Inflation Reduction Act should they win the November elections. https://hubs.li/Q02QBhS20 #IRA #InflationReductionAct
Senate Bill Seeks to Spare Small Biotechs from IRA’s Drug Price Negotiations
biospace.com
-
The positive readout in patients with non-relapsing secondary progressive multiple sclerosis comes on the heels of back-to-back failures in which tolebrutinib was unable to improve relapse rates in patients with relapsing MS. https://hubs.li/Q02QB9p90 #biospace #sanofi Sanofi
Sanofi’s Tolebrutinib Delays MS Progression in Phase III Study Following Earlier Flops
biospace.com
-
Good company culture is a crucial aspect of professional life. Look at these 11 important indications of good workplace culture before accepting a job offer or use them to evaluate your new employer. https://lnkd.in/gGXYTc37 #biospace #workculture
11 Signs of Good Company Culture
biospace.com
-
The drop in interest rate is slightly bigger than anticipated and good news for the biotech industry, but little will change in the near term. https://lnkd.in/gjaE4jjk
After Fed Rate Cut, Biotech Stocks Face ‘Anticlimactic’ Reality
biospace.com
-
AGC Biologics, a Seattle-based contract development and manufacturing organization, will lay off 95 employees effective November 22 according to WARN notices. https://lnkd.in/gadVTmMh #layoffs
Biopharma Layoff Tracker 2024: AGC Biologics, Oncternal, Biosense Webster and More Cut Staff
biospace.com